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ABSTRACT
The cumulative effect of repeated asymptomatic enteric infections on intestinal barrier is not 
fully understood in infants. We aimed to evaluate the association between previous enteric 
parasitic infections and intestinal inflammation and permeability at 24-months of age, in 
asymptomatic infants of São Tomé Island. A subset of infants from a birth cohort, with intestinal 
parasite evaluations in at least four points of assessment, was eligible. Intestinal inflammatory 
response and permeability were assessed using fecal S100A12 and alpha-1-antitrypsin (A1AT), 
respectively. The cutoff <–1SD for weight-for-length and length-for-age was used to define 
wasting and stunting. Multivariable linear regression analysis explored if cumulative enteric 
parasitic infections explained variability of fecal biomarkers, after adjusting for potential 
confounders. Eighty infants were included. Giardia duodenalis and soil-transmitted helminths 
(STH) were the most frequent parasites. The median (interquartile range) levels were 2.87 μg/g 
(2.41–3.92) for S100A12 and 165.1 μg/g (66.0–275.6) for A1AT. Weak evidence of association was 
found between S100A12 levels and G. duodenalis (p = 0.080) and STH infections (p = 0.089), 
and between A1AT levels and parasitic infection of any etiology (p = 0.089), at 24-months of 
age. Significant associations between A1AT levels and wasting (p = 0.006) and stunting (p = 
0.044) were found. Previous parasitic infections were not associated with fecal biomarkers 
at 24  months of age. To summarize, previous asymptomatic parasitic infections showed no 
association with intestinal barrier dysfunction. Notwithstanding, a tendency toward increased 
levels of the inflammatory biomarker was observed for current G. duodenalis and STH infections, 
and increased levels of the permeability biomarker were significantly associated with stunting 
and wasting.
Introduction
Enteric infections, including those caused by parasites, 
are defined as pathogen-associated disrupted intestinal 
absorptive and/or barrier function, with or without overt 
diarrhea [1] and may have devastating consequences on 
the infant growth [2,3], and neurodevelopment [4,5]. 
Two recent comprehensive multinational studies Global 
Enteric Multicenter Study [6] (GEMS) and Malnutrition 
and Enteric Disease (Mal-ED) Study [7], carried out in 
developing countries, highlight the role of protozoan 
as etiologic agents of enteric infections in the first two 
years of life, particularly Cryptosporidium spp. associated 
to moderate-to-severe diarrhea and Giardia duodenalis 
in asymptomatic infected infants. The soil transmitted 
helminths (STH) Ascaris lumbricoides, Trichuris trichiura, 
and hookworms, highly prevalent in infants from poor 
settings, also may be a cause of enteric infections [8].
Increased intestinal permeability and local inflamma-
tory response are mechanisms by which enteric infec-
tions can cause epithelial damage [9,10]. The assessment 
of these phenomena is important for the understanding 
of gut-infection interaction. Parasitic enteric pathogens 
can disrupt the intestinal barrier directly, by binding to 
cell surface molecules, causing cell damage and apop-
tosis, or by disrupting tight junctions and cell cytoskele-
ton [9,10] as described in Cryptosporidium spp. [11,12], G. 
duodenalis [13,14] and STH infections [15,16]. The sever-
ity of the intestinal inflammatory response is variable and 
dependent on the immune status of the host, parasite 
invasive potential, and ecological niche [17]. At intesti-
nal level, parasite may induce a robust innate mucosal 
immune response that includes activation of neutrophils 
and other cells which may participate in the intestinal 
lesion [18], as described in Cryptosporidium spp. [19], G. 
duodenalis [20,21], and STH infections [22].
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Tomé, Island that belongs to the Republic of São Tomé 
and Príncipe, a low-middle income country of sub-Sa-
haran Africa. The birth cohort included 500 appro-
priate-for-gestational age infants (>10th and <90th 
percentiles) recruited within the first 28 postnatal days, 
from March to June 2013, and followed-up to 24 months 
of age. Neonates with low birth weight (<2500 g), born 
preterm (<37 weeks of gestation), without gestational 
age information, or with major congenital malformations 
were excluded. Infants were recruited at the mother-in-
fant health care center in the main district Água Grande, 
and in the local hospitals in Lembá and Caué districts.
In this cohort study, follow-up was scheduled for 
anthropometric measurements, neurodevelopment 
assessment, and intestinal parasites examination, 
approximately at 3, 6, 9, 12, 16, 18, and 24 months of 
age. To assess the cumulative exposure to enteric para-
sitic infections, a minimum of four points of assessment 
(at 6, 12, 18 and 24 months) were required, which coin-
cided with semestral appointments for feeding advice 
and scheduled immunizations. The subset of infants 
complying with this criterion was selected for a single 
measurement of fecal biomarkers of intestinal barrier 
function at 24 months of age.
Written informed consent in the national official 
language (Portuguese) was obtained from parents or 
caregivers. A local nurse in each health care setting repre-
sented the parents or caregivers and signed the consent 
in case of subjects having language/literacy difficulties. 
The study was approved by the Ministry of Health of 
São Tomé and Principe and by the Institute of Tropical 
Medicine and Hygiene ethics committee.
Clinical data and anthropometry
Socio-demographic data regarding mothers’ educa-
tional level and household data were recorded, includ-
ing improved drinking water source and sanitation 
availability [43]. In each visit, feeding practices (breast-
feeding, formula feeding, and complementary feeding), 
and clinical events were recorded if they occurred or 
were still occurring in the week prior to visit, including 
acute diarrhea (lasting  <  14  days), persistent diarrhea 
(lasting > 14 days), respiratory symptoms, and malaria 
(confirmed by Rapid Diagnostic Test and/or blood smear 
microscopic identification).
Anthropometry was performed in duplicate by the 
same trained observer (MG) in each point assessment. 
Infants were weighed using an electronic baby scale to 
the nearest decigram and crown-heel length measured 
using an infantometer, to the nearest millimeter. The 
z-scores for weight-for-age (WAZ), weight-for-length 
(WLZ) and length-for-age (LAZ) were calculated using 
the WHO Anthro software v.3.2.2. Wasting and stunting 
were defined by WLZ and LAZ, respectively; in this study, 
the cut-off <–1SD was chosen by convenience to allow 
The aforementioned mechanisms were investigated 
using in vitro and animal models, which may not accu-
rately reflect the intricate in vivo dynamics of the mucosal 
immune system in humans [10]. Several clinical stud-
ies have been carried out in children from developing 
countries to explore intestinal injury associated with 
enteric parasitic infections. The intestinal inflammatory 
response has been studied using systemic biomarkers 
(e.g., alpha1-antichymotrypsin, alpha-1-acid glycopro-
tein, and cytokines) [23–25], or fecal biomarkers (e.g., 
cytokines, lactoferrin, calprotectin, neopterin, myelop-
eroxidase) [26–30]. Fecal S100A12 is a calcium-bind-
ing pro-inflammatory protein restrictelly secreted by 
activated neutrophils, used as a noninvasive specific 
biomarker of intestinal inflammation [31]. In children, 
it is reported to have higher sensitivity and specificity 
in inflammatory bowel disease than other markers [32]. 
To the best of our knowledge fecal S100A12 was never 
used as biomarker of inflammation in enteric parasitic 
infections. For intestinal permeability, biomarkers such 
as urinary lactulose/mannitol absorption test, fecal A1AT, 
serum endotoxin core antibody, and zonuline test are 
the most frequently used biomarkers [30,33–35]. Fecal 
A1AT is classically used as a simple diagnostic method 
for protein-losing enteropathies [36]. In children, fecal 
A1AT was shown to be a convenient, cheap and sensitive 
method to indirectly assess the intestinal permeability in 
several gastrointestinal diseases, particularly in enteric 
infections [30,37,38], and environment enteropathy dys-
function [30,39,40].
Infancy is a period of rapid gastrointestinal develop-
ment and the mucosal barrier function may not be fully 
established until after the second year of life [41]. The first 
2 years of age is a critical period in which impaired intesti-
nal absorptive function may result from repeated enteric 
infections, even in those without overt liquid diarrhea 
[42]. The less explored cumulative effect of exposure to 
repeated asymptomatic parasitic infections on the intes-
tinal barrier motivated our study.
We aimed to evaluate the association between pre-
vious exposure to enteric parasitic infections and intes-
tinal inflammation and permeability at 24-months of 
age, in asymptomatic infants from São Tomé Island. Fecal 
S100A12 and A1AT were used as biomarkers for intestinal 
inflammation and permeability, respectively. We hypoth-
esize that previous exposure to asymptomatic enteric 
parasitic infections is associated with local inflammation 
and increased intestinal permeability at 24 months of 
age.
Methods
This study is nested within a birth cohort study aimed 
to determine the association between enteric parasitic 
infections and nutritional status, intestinal barrier func-
tion, and neurodevelopment in infants living in São 
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the inclusion of infants with mild-to-moderate under-
nutrition [44].
Parasite examination techniques
For each point assessment, parents collected a single 
stool sample at home on the day before or on the same 
day of the evaluation visit, using a sterile container pro-
vided by the research team. Collected samples were 
stored at 4 °C in the local laboratory and processed on 
the same day of reception.
Microscopic ova and parasite examination was per-
formed in iodine-stained wet mounts of feces dissolved 
in saline and after formol-ether concentration proce-
dure [45]. A cold acid-fast Kinyoun stain (Biomerieux®) 
was used for Cryptosporidium spp. and coccidian spe-
cies (Cystoisospora and Cyclospora) detection. The same 
trained observer (MG) performed these microscopic 
examinations. A Rapid test for G. duodenalis detection 
(STICK Giardia/simple Giardia Operon, Immune and 
Molecular diagnostics) was used for liquid stool sam-
ples. Examinations for bacterial and viral enteropatho-
gens were not performed due to logistical and economic 
constraints.
Additionally, three aliquots of each stool sample were 
transported to the Institute of Tropical Medicine and 
Hygiene Laboratory in Lisbon. Two aliquots (one pre-
served in Protofix TM® Alphatec, and another obtained 
from the formol–ether sedimentation) were stored at 4 °C 
for a second microscopic exam by an independent expe-
rienced observer (AR) at the Institute of Tropical Medicine 
and Hygiene Laboratory. The third aliquot was stored 
for up to 6 months at −20 °C without preservative, for 
molecular characterization of G. duodenalis and detec-
tion of fecal markers by enzyme linked immunosorbent 
assay (ELISA). The aforementioned time of storage and 
temperature are reported to have low impact on protein 
(S100A12 and A1AT) concentrations [46].
Microscopically positive stool samples for G. duode-
nalis at 24 months were processed for molecular charac-
terization. DNA was extracted from the stools stored at 
−20 °C, using the QIAamp DNA Stool Mini Kit (Qiagen). 
Amplification of the fragments from ssurRNA (175 bp) 
and β-giardin (511  bp) genes was performed accord-
ing to previously described protocols [47]. PCR prod-
ucts were purified using illustra GFX PCR DNA and Gel 
Band Purification Kit (GE HealthCare Life Sciences) and 
sequenced from both strands. The obtained sequences 
were aligned with published sequences of G. duodenalis 
isolates available in the GenBank database, using Clustal 
Omega and BioEdit 7.0.9 software for subassemblage 
determination.
It should be noted that after delivery of stool sam-
ples at each point evaluation, infants older than 1 year 
received mebendazole every four months, in compliance 
with the WHO preventive chemotherapy strategy for STH 
[48] implemented by the Health Ministry of São Tomé 
and Principe. Additionally, infants were treated for G. 
duodenalis with metronidazole suspension (provided 
by the research team) in case of microscopic detection 
of trophozoite (independently of symptoms) or in case of 
detection of cysts or a positive rapid test only in sympto-
matic infants, according to the current recommendations 
[49].
Fecal biomarkers
The analysis of fecal biomarkers was performed in stool 
samples stored at –20 °C. Temperatures during transpor-
tation never exceed 18 to 25 °C as recommended. Stool 
samples were processed for S100A12 (Inflamark F-INFL-
ELISA Cisbio Bioassays) and for A1AT (RIDASCREEN α1-An-
titrypsin R-Biopharm) determination by using the ELISA 
technique following the manufacturers’ instructions. 
Samples out of the range of standard curve were run 
at higher or lower concentrations as appropriate. For 
S100A12, the absorbance was read at wavelength of 
450  nm; final concentrations, expressed in μg/g, were 
derived from a calibration curve using a 3rd-degree pol-
ynomial extrapolation. For A1AT, the absorbance was 
read at 450 nm with a reference wavelength of 620 nm; 
final concentrations expressed in μg/g were obtained 
using a four-parameter logistic-log model. As the afore-
mentioned tests measure protein (A1AT and S100A12) 
concentrations, these are more accurately determined 
using dry weight or standardized dilution of specimens 
[30]. Therefore, watery or diarrheal stool samples were 
excluded from the analysis.
Statistical analysis
Socio-demographic characteristics, feeding practices, 
clinical events, anthropometric measures, and labora-
tory findings were described with frequencies (percent-
ages) and with mean (SD: standard deviation) or with 
median and interquartile range (P25 – P75), as appropriate. 
Linear regression analysis was used to explore if cumu-
lative enteric parasitic infections (including previous 
and current infections, etiology, and single or multiple 
infections) explained the variability of fecal markers, 
measured at 24 months. Potential confounders such as 
sex, feeding practices, and nutritional status were con-
sidered in this analysis. In the univariate regression anal-
ysis, all the variables with a p-value < 0.25 were selected 
for the multivariable models. Normality assumption of 
the residuals was verified using Kolmogorov–Smirnov 
goodness-of-fit test with Lilliefors correction. A loga-
rithmic transformation of S100A12 and A1AT values was 
performed as this assumption has been violated. A level 
of significance of α = 0.05 was used, although p-values 
greater than 0.05 and lower than 0.1 (weak evidence of 
the difference/association) were still considered [50]. 
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variation preceded the LAZ variation (Figure 2). At the 
end of the study at 24 months of age, 23% of infants were 
stunted and 10% wasted; from these, only five infants 
were moderately-to-severely (<–2SD) stunted and none 
was moderately-to-severely (<–2SD) wasted.
Parasitic infection
During the study period 497 stool samples were exam-
ined for intestinal parasites. The frequencies of intes-
tinal pathogenic parasites at each point assessment 
are shown in Table 1. Parasites were not detected at 
3  months of age; subsequently, the frequency of par-
asitic infection increased progressively with age, from 
7.9% at 6 months to 57.5% at 24 months of age. Single 
parasitic infections predominated. Co-infections were 
detected from 12  months of age and their frequency 
increased up to the end of the study. The three most fre-
quent pathogenic parasites, either as single or multiple 
infection, were by decreasing order G. duodenalis, STH, 
and Cryptosporidium spp. (Table 1). Entamoeba histolyt-
ica/ dispar complex was not detected. Other pathogenic 
parasites detected are shown in Table 1.
In the entire study period, 1 to 2 episodes of parasitic 
infection occurred in 39 (48.8%) infants, 3 to 4 episodes in 
26 (32.5%) infants, and more than 4 episodes in 5 (6.3%) 
infants, independently of the etiology, either as single or 
multiple agent infection. In 11 (13%) infants no parasite 
was found.
From the 30 stool samples with a positive micros-
copy for G. duodenalis at 24 months of age, only 28 had 
enough material to be processed for molecular charac-
terization. Twelve samples were successfully amplified for 
β-giardin, 14 for ssu-rRNA fragment gene, and two failed 
to amplify. Eighty percent (20/25) of samples belonged 
to Assemblage B and 20% (5/25) to Assemblage A. 
Additionally, β-giardin sequences were analyzed for sub-
assemblage discrimination according to the described 
genetic polymorphisms. Nine isolates belonged to sub-
assemblage B3, and 3 to subassemblage A3.
Data were analyzed using the software SPSS 22.0 (SPSS 
for Windows, Rel. 22.0.1. 2013. SPSS Inc., Chicago, IL, EUA) 
and Stata (Stata Statistical Software: Release 13. College 
Station, TX: StataCorp LP).
Results
From the birth cohort, 283 infants completed 24 months 
of follow–up; from these, 82 were eligible for fecal bio-
markers determinations, but two were subsequently 
excluded due to acute severe conditions. Thus, a final 
sample of 80 infants (Figure 1) was included, in which 
57.5% were females. Sex distribution and anthropomet-
ric data did not significantly differ between included and 
excluded infants (data not shown). In the final sample, 
81.3% of mothers had more than five years of school edu-
cation, 98.8% of the households had improved drinking 
water source, and 72.5% improved sanitation. In relation 
to feeding practices, 98.8% of infants were breastfed at 
some time point, 77.5% were exclusively breastfed 
at 6  months, and 10% maintained breastfeeding at 
24  months; the mean (SD) duration of breastfeeding 
was 16.7 (2.9) months, and the mean (SD) age of intro-
duction of complementary feeding was 5.7 (1.0) months. 
The frequency of clinical events varied along the study 
period, the respiratory symptoms (most frequent) varied 
between 10.5 and 37.2% of cases, and acute diarrhea 
between 1.3 and 9.3%; one case of persistent diarrhea 
and one of malaria were registered. In most infants the 
anthropometric measures were within the normal range 
at neonatal period, with a mean (SD) weight of 3.46 (0.46) 
kg and length of 50.2 (1.95) cm. After the neonatal period 
and up to 24 months of age, the rate of wasted infants 
varied between 4.3% and 16.2%, and of stunted infants 
between 19.1 and 35.1% (Figure 2). Noteworthy, the WLZ 
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LAZ < -1 SD WLZ < -1 SD
Figure 2.  Wasting (WlZ) and stunting (laZ) patterns up to 
24 months of age. WlZ weight-for-length z-score; laZ length-
for-age z-score.
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Discussion
This prospective study, conducted in a low-middle 
income African country, showed that 87% of infants 
were infected by at least one pathogenic parasite in 
the first two years of life. Enteric parasitic infection was 
diagnosed as early as at 6 months of age, with frequency 
increasing with age and affecting around half of the 
infants at 24  months. G. duodenalis was the most fre-
quently isolated parasite followed by STH, only detected 
after 12 months of age. Low frequencies were found for 
Cryptosporidium spp. In Africa, few longitudinal studies 
have assessed the prevalence of enteric parasitic infec-
tions in infants and recognized a high burden of para-
sitism during the first years of life [8,23], as in our study. 
During the study, most of the infants were asympto-
matic, suggesting colonization and the development of a 
possible mutualistic or commensal relationship with the 
host. Moreover, the pathogenic role of parasites isolated 
in asymptomatic infants is difficult to interpret, because 
it may represent convalescent excretion of enteropatho-
gens after acute diarrhea rather than true asymptomatic 
infection [51].
Regarding intestinal inflammation, a weak evidence of 
association was found between fecal S100A12 levels and 
current G. duodenalis and STH infections at 24 months of 
age. This association may be clinically meaningful, since 
this tendency toward increased fecal S100A12 levels was 
noticeable with the most frequent parasites. Classically, 
G. duodenalis infection is characterized by little or no 
inflammatory intestinal response [52]. In young children 
Fecal biomarkers
Fecal biomarkers were tested in 80 infants for A1AT, 
and in 74 for S100A12 due to unsolvable technical con-
straints. The fecal S100A12 median (interquartile range) 
level was 2.87 (2.41–3.92) μg/g and of A1AT was 165.1 
(66.0–275.6) μg/g (Table 2). A descriptive statistics of 
both biomarkers by the categories of several variables 
and distribution of their values is shown in Table 2 and 
Figure 3, respectively.
Variables with a p-value < 0.250 obtained in the uni-
variable analysis (Table 3) were selected for the multi-
variable analysis. Results from the multivariable models 
(Table 4) showed a weak evidence of an association 
between fecal S100A12 levels and current G. duode-
nalis infection (p = 0.080) and between fecal S100A12 
levels and current STH infection (p  =  0.089). This sug-
gests an increasing tendency of 23.6% and 24.1% in 
fecal S100A12 levels in infants infected with G. duode-
nalis and STH, respectively. Similarly, a weak evidence 
of an association was found between fecal A1AT levels 
and current parasitic infection of any etiology (p = 0.089), 
suggesting an increasing tendency of 33.6% higher A1AT 
levels in infected infants. Remarkably, significant associa-
tions were found between fecal A1AT levels and wasting 
(p = 0.006) and stunting (p = 0.044) at 24 months of age; 
specifically, fecal A1AT levels were twice higher in wasted 
infants and 50% higher in stunted infants. No significant 
associations between either fecal S100A12 or fecal A1AT 
and parasitic infection before 24 months of age (includ-
ing number and etiology), were found.
Table 1. Frequency of intestinal pathogenic parasites by age.
note: na not available.
aParasite examination was included in the analysis of the cumulative effect of enteric parasitic infections before 24 months of age.
Stool samples = 497
3 months 6 months 9 monthsa 12 months 16 monthsa 18 months 24 months
n = 74 n = 76 n = 52 n = 78 n = 71 n = 70 n = 80
Infected (%) (n) 0 (0) 7.9 (6) 15.4 (8) 25.6 (20) 45.1 (32) 42.8 (30) 57.5 (46)
single Infections (%)(n) 0 (0) 7.9 (6) 15.4 (8) 21.8 (17) 40.9 (29) 32.8 (23) 42.5 (34)
Protozoa (%)(n)
Giardia duodenalis 0 (0) 6.6 (5) 9.6 (5) 11.5 (9) 22.5 (16) 22.9 (16) 26.3 (21)
Cryptosporidium spp. na 1.3 (1) 5.8 (3) 3.8 (3) 2.8 (2) 1.4 (1) 3.75 (3)
Entamoeba histolytica/dispar complex 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Cystoisospora belli 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
soil transmitted helminths (sth) (%)(n)
Ascaris lumbricoides 0 (0) 0 (0) 0 (0) 5.1 (4) 15.5 (11) 4.3 (3) 10.0 (8)
Trichuris trichiura 0 (0) 0 (0) 0 (0) 1.3 (1) 0 (0) 2.9 (2) 2.50 (2)
Necator americanus/Ancylostoma duodenale 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Strongyloides stercoralis 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1.4 (1) 0 (0)
Multiple Infections (%)(n) 0 (0) 0 (0) 0 (0) 3.9 (3) 4.2 (3) 10.0 (7) 15.0 (12)
G. duodenalis + Cryptosporidium spp. 0 (0) 0 (0) 0 (0) 0 (0) 1.4 (1) 1.4 (1) 1.25 (1)
G. duodenalis + A. lumbricoides 0 (0) 0 (0) 0 (0) 1.3 (1) 1.4 (1) 0 (0) 5.0 (4)
G. duodenalis + T. trichiura 0 (0) 0 (0) 0 (0) 1.3 (1) 0 (0) 5.7 (4) 3.75 (3)
Cryptosporidium spp. + A. lumbricoides 0 (0) 0 (0) 0 (0) 1.3 (1) 0 (0) 0 (0) 2.50 (2)
Cryptosporidium spp. + T. trichiura 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1.25 (1)
A. lumbricoides + T. trichiura 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2.9 (2) 0 (0)
G. duodenalis + Cryptosporidium + T. trichiura 0 (0) 0 (0) 0 (0) 0 (0) 1.4 (1) 0 (0) 0 (0)
G. duodenalis + A. lumbricoides + T. Trichiura 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1.25 (1)
total Giardia duodenalis (single or multiple) 
(%)(n)
0 (0) 6.6 (5) 9.6(5) 14.1 (11) 26.8 (19) 30 (21) 37.5 (30)
total Cryptosporidium spp. (single or multiple) 
(%)(n)
0 (0) 1.3 (1) 5.8 (3) 3.8 (3) 5.6 (4) 2.8 (2) 8.7 (7)
total sth (single or multiple) (%)(n) 0 (0) 0 (0) 0 (0) 10.2 (8) 18.3 (13) 20 (14) 27.5 (22)
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explanation for our findings may be the predominant 
existences of assemblage B (80.0%) in our sample, as 
described in other African countries [55,56]. This gen-
otype has been associated to extensive damage of the 
mucosal architecture and infiltration of inflammatory 
cells [21,57]. Very few studies have explored the effects 
of STH infections on mucosal immunity in infants [58]. 
In early STH infections, Zanzibari infants showed a reg-
ulatory Th2 pattern of peripheral cytokine responses to 
Ascaris and hookworm antigens [59], without association 
with acute phase proteins [60]. In our study, the tendency 
toward increased fecal S100A12 levels in current STH 
infections may suggest the presence of local inflam-
matory response mediated by neutrophils. In murine 
models using Heligmosomoides polygyrus, an early and 
pronounced infiltration of neutrophils and macrophages 
from developing countries G. duodenalis is usually 
asymptomatic, probably as a result of modulation of the 
innate immune system [53] or a decrease of inflammatory 
response in subsequent infections [20,29]. Previous stud-
ies reported the association between G. duodenalis and 
biomarkers of intestinal inflammation in children [28,29], 
while others did not [30]. In the recent MAL-ED study, 
fecal myeloperoxidase, a marker of neutrophil inflam-
mation, was surprisingly lower in children with Giardia 
[30]. In our study, despite the fact that most infants with 
Giardia infection were asymptomatic, the tendency 
toward increased fecal S100A12 levels may suggest local 
inflammatory response with participation of neutrophils. 
Histopathological studies using murine models showed 
intestinal infiltration of neutrophils that persisted several 
days after G. duodenalis infection [21,54]. One plausible 
Table 2. Fecal values of alpha1-anti-trypsin (a1at) and s100a12 at 24 months of age, considering sex, parasite agent, and nutritional 
status categories.
ap values obtained by student’s t-test after logarithmic transformation of a1at and s100a12.
  A1AT (μg/g) S100A12 (μg/g)  
n median (P25 – P75) p value
a n median (P25 – P75) p value
a
Whole sample 80 165.1 (66.0–275.6)   74 2.9 (2.4–3.9)  
 girls 46 151.4 (66.0–272.4) 0.669 42 3.0 (2.6–4.4) 0.340
 boys 34 175.9 (66.0–291.4)   32 2.8 (2.3–3.5)  
Infected by any intestinal parasite
 no 34 129.6 (66.0–242.6) 0.131 33 2.7 (2.2–3.7) 0.075
 Yes 46 184.3 (66.0–325.5)   41 3.1 (2.7–4.4)  
Giardia duodenalis 
 no 50 143.0 (66.0–245.8) 0.143 49 2.8 (2.3–3.7) 0.068
 Yes 29 200.6 (66.0–389.9)   25 3.2 (2.5–5.3)  
Cryptosporidium spp.
 no 72 153.2 (66.0–278.7) 0.656 67 2.9 (2.4–3.9) 0.589
 Yes 7 167.1 (115.7–314.9)   7 3.0 (2.7–3.5)  
soil transmitted helminths
 no 58 159.3 (66.0–289.4) 0.675 53 2.8 (2.2–3.9) 0.075
 Yes 21 162.9 (66.0–261.7)   21 3.1 (2.6–4.7)  
Multiple infections 
 no 68 159.3 (66.0–269.1) 0.446 62 2.8 (2.2–3.9) 0.093
 Yes 12 169.5 (78.4–404.1)   12 3.2 (2.9–5.4)  
stunting
 no 61 151.4 (66.0–248.6) 0.053 56 2.9 (2.4–3.9) 0.750
 Yes 18 236.6 (104.3–510.8)   18 3.0 (2.3–4.3)  
Wasting 
 no 71 151.4 (66.0–256.9) 0.008 66 2.9 (2.3–3.9) 0.574
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Figure 3. distribution of fecal s100a12 (n = 74) and fecal alpha-1 anti-trypsin (n = 80) at 24 months of age.
122   M. GARZÓN ET AL.
children from a developed country [65,66], and meas-
ured using different ELISA method [67]. To the best of our 
knowledge, this is the first time that S100A12 is used to 
assess intestinal inflammatory response in enteric para-
sitic infection in children. This biomarker was chosen tak-
ing into account its advantages in field studies involving 
children. This protein is restrictively secreted by activated 
neutrophils and is strongly correlated with histologically 
intestinal inflammation and neutrophil infiltration [68]. 
Fecal S100A12 has a sensitivity of 96% and a specificity 
of 92% in distinguishing healthy children from those 
with inflammatory bowel disease, using the threshold 10  
mg/kg [32,67]. It is evenly distributed throughout feces 
and is stable at a wide range of temperatures (4 to 20 °C) 
for several days [67]. These characteristics make fecal 
S100A12 a convenient biomarker, facilitating samples 
collection and transportation to a laboratory for meas-
urement, avoiding resource-consuming storage needs 
[67]. Several commercial ELISA kits are available for fecal 
S100A12 analysis requiring a small stool sample (approx-
imately 100 mg). Other fecal neutrophil-derived proteins 
used as biomarkers of intestinal inflammation may have 
limitations compared with S100A12, particularly in 
infants. Calprotectin, another calcium and zinc-binding 
protein, is present in neutrophils, but also in monocytes 
and macrophages [69]. Fecal calprotectin correlates well 
with endoscopic and histological inflammatory bowel 
in regions immediately adjacent to the parasite has been 
described [61]. Furthermore, primary infections by STH, 
as occurring in younger children, may stimulate a strong 
inflammatory response in the mucosa [58]. Young chil-
dren in developing countries frequently respond to 
Cryptosporidium infection with intestinal inflammation 
[27]. In our study Cryptosporidium spp. was not associ-
ated with the fecal inflammatory biomarker, probably 
explained by its low frequency and less severe infections 
in asymptomatic infants.
The fecal biomarkers have the advantage of measur-
ing proteins originating in the intestinal mucosa, more 
accurately reflecting local inflammation [62]. Several 
fecal biomarkers of neutrophil activity (e.g., lactoferrin, 
myeloperoxidase, and calprotectin) or of activated cell 
mediated immunity (e.g., neopterin) have been used to 
assess intestinal inflammation in infants [63]. High lev-
els of these biomarkers were reported in infants from 
developing countries associated either to enteric par-
asite infections [24,27–30] or to environmental enteric 
dysfunction [30,39,40,64]. In accordance, we found high 
median fecal levels of S100A12 in all infants at 24 months 
of age, five times above those described for healthy chil-
dren (0.5 mg/kg), but below the threshold 10 mg/kg used 
for inflammatory bowel disease [65,66]. This comparison 
should be interpreted with caution, since the reported 
values were obtained from a limited number of healthy 
Table 3. Univariable analysis for fecal alpha1-anti-trypsin (a1at) and s100a12, considering sex, parasitic infection before and at 
24 months of age, nutritional status, and feeding practices.
notes: ln logarithmic transformation, sth soil transmitted helminths.
aΣWaZ bΣWlZ cΣlaZ sum up of weight-for-age, weight-for-length, and length-for-age z-scores, respectively, at all point assessments dp values obtained by 
linear regression models after logarithmic transformation of a1at (ln a1at) and s100a12 (ln s100a12) values.
Variables 
ln A1AT ln S100A12
β-estimate (95%CI) p valued β-estimate (95%CI) p valued
Females 0.08 (–0.28; 0.44) 0.669 –0.113 (–0.35; 0.12) 0.340
Parasitic infection before 24 months of age
nr. parasites 0.11 (–0.05; 0.272) 0.181 0.10 (–0.00; 0.20) 0.054
nr. G. duodenalis 0.14 (–0.07; 0.36) 0.198 0.11 (–0.02; 0.25) 0.106
nr. Cryptosporidium spp. 0.11 (–0.34; 0.55) 0.638 0.07 (–0.22; 0.37) 0.624
nr. sth 0.03 (–0.25; 0.30) 0.840 0.08 (–0.09; 0.25) 0.373
Parasitic infection at 24 months of age
Infected at 24 months 0.27 (–0.08; 0.62) 0.131 0.21 (–0.02; 0.43) 0.075
nr. parasites 0.21 (–0.03; 0.44) 0.087 0.15 (0.00; 0.30) 0.047
G. duodenalis 0.27 (–0.09; 0.63) 0.143 0.22 (–0.01; 0.46) 0.068
Cryptosporidium spp. 0.14 (–0.45; 0.77) 0.656 –0.11 (–0.50; 0.29) 0.589
sth 0.09 (–0.31; 0.49) 0.675 0.23 (–0.02; 0.48) 0.075
Multiple infections 0.19 (–0.30; 0.69) 0.446 0.27 (–0.04; 0.57) 0.093
Nutritional status
Mean ΣWaZa –0.22 (–0.45; –0.00) 0.054 –0.03 (–0.18; 0.12) 0.692
Mean ΣWlZb –0.07 (–0.33; 0.19) 0.589 –0.03 (–0.20; 0.13) 0.682
Mean ΣlaZc –0.28 (–0,50; –0,07) 0.011 –0.03 (–0.17; 0.12) 0.732
Underweight at 24 months 0.21 (–0.21; 0.64) 0.321 0.07 (–0.20; 0.34) 0.636
Wasting at 24 months 0.77 (0.21; 1.34) 0.008 0.10 (–0.27; 0.48) 0.574
stunting at 24 months 0.41 (–0.01; 0.83) 0.053 0.04 (–0.23; 0.32) 0.750
Feeding practices
ever breastfeeding –0.82 (–2.40; 0.76) 0.306 –0.07 (–1.01; 0.93) 0.880
exclusive breastfeeding at 
6 months 
0.14 (–0.32; 0.61) 0.543 0.13 (–0.17; 0.44) 0.391
age (months) of introduction 
complementary foods 
0.11 (–0.07; 0.28) 0.238 0.02 (–0.01; 0.14) 0.750
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two inflammatory biomarkers (myeloperoxidase and 
neopterin) in a score to predict growth deficit in infants 
[40]; specifically, fecal A1AT levels at or above 75th were 
reported to predict a loss of 0.152 LAZ in the subse-
quent six months [40]. Similar results were described 
in Brazilian infants [39]. In our study, the convenience 
threshold of 1SD for WLZ and LAZ was used to define 
wasting and stunting. A higher number of undernour-
ished infants due to the inclusion of mild-to-moderate 
degrees may be responsible for the significant associa-
tion we found. In fact, the hazardous effects of undernu-
trition happen along a continuum spectrum, in which 
mild-to-moderate degrees may be associated with oth-
erwise-unobserved changes in disease exposure [44,80]. 
Marginally nourished children may have inadequate or 
rate-limiting stores of key nutrients to repair the mucosal 
damage [42]. Despite the aforementioned association of 
fecal A1AT levels with stunting and wasting, the median 
A1AT level of 165.1 μg/g found in our sample was below 
the mean 299 μg/g described in infants from develop-
ing countries [30]. Most of the studies have used urinary 
lactulose:mannitol ratio to assess intestinal permeability 
[81]. In our study, fecal A1AT was preferred instead of 
lactulose:mannitol test considering some advantages. 
The AAT is neither degraded by intestinal proteases 
nor reabsorbed and it is notably stable in stool samples 
[82]. Furthermore, large size molecules such as A1AT 
(50,000 Da), transported through the paracellular route, 
may better reflect structural damage of tight junctions 
than small size molecules such as lactulose (342 Da) and 
mannitol (182 Da) [83]. Moreover, the lactulose:mannitol 
test has inconveniences that may limit its use in infants, 
particularly in field settings, such as the requirement of 
fasting before testing, the need for several hours for urine 
collection, the lack of standardized procedures, and of 
reference values for children [81].
The suspected effect of repeated enteric infections 
on intestinal function [42] was recently confirmed by a 
better correlation of fecal biomarkers with cumulative 
pathogen burden than with a single ongoing infection 
[30]. In spite of this evidence, we found no associations 
between previous exposure to asymptomatic parasitic 
infections and fecal biomarkers of intestinal inflamma-
tion and permeability at 24 months of age. Since these 
biomarkers were not measured longitudinally, a revers-
ible process of intestinal epithelial injury [33] cannot 
be excluded; otherwise, asymptomatic infections may 
induce less severe intestinal barrier dysfunction than 
symptomatic infections [26,76].
The following constitute strong points of our study. 
The measurement of intestinal barrier biomarkers at 
24 months, and not before, reflects more accurately the 
impact of parasite infection, not biased by a potential 
effect of an incomplete development of mucosal barrier 
function [30,41]. The longitudinal search for intestinal 
parasites included not only protozoa but also STH, 
providing a broader view of the association between 
disease activity [70] but a meta-analysis showed a rel-
atively low pooled specificity (0.76) in children [71]. It 
seems to be a less accurate biomarker for inflammatory 
bowel disease than fecal S100A12 in pediatric population 
[32]. In healthy infants, fecal calprotectin levels are higher 
than in older children [72], and in those breastfed [73], 
Lactoferrin is likewise not specific, as it is produced by 
neutrophils and epithelial cells [74], It may be inaccurate 
to determine intestinal inflammation in infants using this 
biomarker, since breast milk may contribute to increase its 
fecal levels [75]. Additionally, fecal lactoferrin may be less 
sensitive in malnourished children [76]. Myeloperoxidase 
is produced by neutrophils, but it is found at lower con-
centrations in monocytes and macrophages [77]. In spite 
of a good correlation of fecal myeloperoxidase with labo-
ratory and endoscopic parameters of inflammation [77], 
recent breastfeeding is also associated with increased 
fecal levels [30]. Furthermore, gender differences, with 
lower intracellular neutrophil myeloperoxidase levels in 
boys, have been reported [78]. Neopterin, an indicator of 
T-helper cell 1 activity, is used as a biomarker of intestinal 
inflammation [28,30,39,40]. Its fecal levels were found to 
be much higher (26 times) in infants from developing 
countries than from non-tropical countries [30,40].
Regarding intestinal permeability, a weak evidence 
of association was found between fecal A1AT levels and 
current parasitic infection of any etiologic at 24 months 
of age. This association may have limited clinical rele-
vance, since the tendency toward increased fecal A1AT 
levels was associated with unspecific etiology. Several 
studies (most using lactulose:mannitol test) described 
the association between enteric parasitic infection and 
increased intestinal permeability [23,30,33,34], while 
others did not [25,28]. Significant associations were 
found between increased fecal A1AT levels and both 
acute (wasting) and chronic (stunting) undernutrition 
at 24  months of age, independently of intestinal par-
asitic infection. The association between increased 
intestinal permeability and undernutrition has been pre-
viously described in infants from developing countries 
[25,28,35,39,40]. It has been suggested that increased 
intestinal permeability explains at least 40% of growth 
faltering [79]. Recently, fecal A1AT was combined with 
Table 4. Multivariable regression models for alpha1-anti-trypsin 
(a1at) and s100a12.
notes: β regression coefficient, CI confidence interval.
ap values obtained by linear regression models after logarithmic transfor-
mation of a1at(ln a1at) and s100a12 (ln s100a12) values.
Variables β-estimate (95%CI) p value a
  ln a1at  
Parasitic infection at 24 months 
of age
0.29 (–0.05; 0.62) 0.089 
Wasting at 24 months of age 0.78 (0.23; 1.33) 0.006 
stunting at 24 months of age 0.41 (0.01; 0.80) 0.044 
  ln s100a12  
Giardia duodenalis at 24 months 
of age
0.21 (–0.03; 0.45) 0.080 
soil transmitted helminths at 
24 months of age
0.22 (–0.03; 0.47) 0.089 
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